Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Innovative Data Featuring Nanox AI Cardiac Solution Showcased at SCCT 2024
-
Carpenter Technology Reports Fourth Quarter and Fiscal Year 2024 Results
-
Lumerin Launches Morpheus Public Testnet for Decentralized AI Compute
-
scPharmaceuticals Announces Filing Acceptance of Supplemental New Drug Application (sNDA) Seeking to Expand FUROSCIX Indication to Include Chronic Kidney Disease
-
DYPER Awarded “Disposable Diaper Product of the Year” In 2024 Baby Innovation Program
-
Tonix Pharmaceuticals Granted Fast Track Designation by FDA for Tonmya™ for Fibromyalgia
-
Enviri releases annual ESG Report showcasing significant progress toward sustainability goals
-
CIRA’s $1.25 million Net Good Grants investment empowers youth and underserved groups to make Canada’s internet a better place
-
Windtree Therapeutics Provides Update on Istaroxime Clinical Development and Upcoming Clinical Trial Data
-
Lexicon Pharmaceuticals to Host Second Quarter 2024 Financial Results Conference Call and Webcast on August 1, 2024
-
Hanmi Financial Declares Cash Dividend of $0.25 per share
-
Integer Holdings Corporation Reports Second Quarter 2024 Results
-
LifeMD to Participate in Two Investor Conferences During August
-
Inotiv, Inc. to Report Fiscal 2024 Third Quarter Financial Results and Host Conference Call on Thursday, August 8, 2024
-
Atlantic International’s Subsidiary, Lyneer Staffing Solutions, Announces Key Expansion in Rock Hill, South Carolina
-
HP Expands Financing Options for Consumers Across All Credit Tiers
-
Achieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 13, 2024
-
Collective Completes Phase 1 Exploration Program at the Princeton Copper Project
-
JumpCloud Introduces Mobile Device Trust to Enhance Employee Productivity Without Compromising Security
-
Sunrun Customers Power Through Multi-Day Outages, Help Neighbors in the Aftermath of Hurricane Beryl
-
Aquestive Therapeutics Reports Positive Topline Data for Anaphylm™ (epinephrine) Sublingual Film from Self-Administration Study
-
Infinite Reality and Global Esports Federation Partner to Transform Global Fan Experiences
-
New Lung Cancer Screening Coverage is just one of the topics on Lung Cancer Foundation of America’s World Lung Cancer Day Social Media Takeover
-
Esperion to Report Second Quarter 2024 Financial Results on August 12
-
Vertex 2024 Mid-Year Sales Tax Rates and Rules Report Reveals Local Governments are Increasingly Dependent on Sales Tax Revenues
-
Zyter|TruCare Announces USPTO Approval of New Healthcare Triage Management System Patent
-
Collegium to Report Second Quarter 2024 Financial Results on August 8, 2024
-
Serviceaide Launches AI-Based ChangeGear Digital Service Platform
-
INmune Bio Inc. to Report Second Quarter 2024 Financial Results and Provide a Corporate Update on Thursday, August 1, 2024
-
GoHealth to Announce Second Quarter 2024 Results on August 8, 2024
-
Hydrofarm Holdings Group, Inc. to Announce Second Quarter 2024 Results on August 8, 2024
-
Independent Bank Corporation Reports 2024 Second Quarter Results
-
ZyVersa Therapeutics Selects Obesity and Related Metabolic Complications as Lead Indication for Inflammasome ASC Inhibitor IC 100
-
Secure, Fair, and Quantum-Driven: The Qrng Randomizer Blockchain by Qrng Solutions Ltd
-
Chemomab Therapeutics Announces $10 Million Private Placement
-
Purple Biotech Receives Extension to Regain Compliance with the Nasdaq’s Minimum Bid Price Rule
-
Fentura Financial, Inc. Announces Second Quarter 2024 Earnings (Unaudited)
-
Toobit Breaks Into the Big Leagues: Ranked As Top 5 Exchange by CoinMarketCap
-
FirstService Reports Second Quarter 2024 Results
-
Checkpoint Therapeutics Announces FDA Acceptance of BLA Resubmission of Cosibelimab for the Treatment of Advanced Cutaneous Squamous Cell Carcinoma
-
FTI Consulting Reports Record Second Quarter 2024 Financial Results
-
Orezone to Commence a 30,000 Metre Discovery Focused Drill Program at Its Flagship Bomboré Gold Mine
-
Plus Therapeutics Showcases Leptomeningeal Metastases Programs at 2024 SNO/ASCO Conference
-
VitalHub Announces Q2 2024 Conference Call Date
-
Altimmune Announces Publication of Clinical Study of Pemvidutide in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Journal of Hepatology
-
Amesite Releases Video Shareholder Update
-
Kelly Announces Second-Quarter 2024 Conference Call
-
BullFrog AI and Lieber Institute for Brain Development Reveal New Insights into Bipolar Disorder Pathways and Potential Drug Targets
-
Crown LNG Announces Selection of IKM Consulting Ltd as Engineering Design Partner for Grangemouth LNG Infrastructure Project
-
Twenty Lung Cancer Advocacy Organizations and 23andMe Come Together to Launch Lung Cancer Genetics Study to Help Advance Research
